Literature DB >> 9116915

Impairment of 11 beta-hydroxylase but not 21-hydroxylase in adrenal 'incidentalomas'.

M Reincke1, M Peter, W G Sippell, B Allolio.   

Abstract

Recent reports have shown an exaggerated response of 17-hydroxyprogesterone in up to 70% of patients with incidentally detected adrenal adenomas ('incidentalomas'). This has been explained by pre-existing 21-hydroxylase deficiency which may be a pathogenetic factor in the development of adrenal tumours. However, other defects in steroidogenesis, such as mild 11 beta-hydroxylase deficiency, could also result in increased 17-hydroxyprogesterone secretion. We therefore studied the glucocorticoid and mineralocorticoid pathways in patients with adrenal 'incidentalomas' by measuring multiple adrenal steroids before and after 1-24 ACTH stimulation. Twenty patients with adrenal 'incidentalomas' (14 females, 6 males) and 27 healthy controls (14 females, 13 males) were studied. All subjects underwent a 1-24 ACTH stimulation test (250 micrograms i.v.) with determination of progesterone, 11-deoxycorticosterone, corticosterone, 17-hydroxyprogesterone, 11-deoxycortisol and cortisol at 0 and 60 min. All steroids were measured by RIA after extraction and HPLC. Patients with 'incidentalomas' had higher stimulated concentrations of 17-hydroxyprogesterone (21.6 +/- 8.4 vs 4.2 +/- 0.3 nmol/I; P < or = 0.001), 11-deoxycortisol (8.1 +/- 1.2 vs 3.6 +/- 0.3 nmol/I; P < or = 0.001), progesterone (8.28 +/- 2.82, vs 1.08 +/- 0.15 nmol/I; P < or = 0.001), and 11-deoxycorticosterone (2.1 +/- 0.39 vs 0.78 +/- 0.12 nmol/I; P = 0.002) compared with controls. In contrast, cortisol and corticosterone concentrations were not different. There was evidence for impairment of 11 beta-hydroxylase activity by an increased 11-deoxycortisol/ cortisol ratio (0.012 +/- 0.003 vs 0.005 +/- 0.001 in controls; P = 0.002) and 11-deoxycorticosterone/ corticosterone ratio (0.04 +/- 0.003 vs 0.015 +/- 0.003; P = 0.003). The conclusions reached were that patients with adrenal 'incidentalomas' have increased responses of precursors of the mineralocorticoid and glucocorticoid pathway including 17-hydroxyprogesterone after stimulation with ACTH. This seems to be caused by impairment of 11 beta-hydroxylase activity rather than by impaired 21-hydroxylase activity in these tumours.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9116915     DOI: 10.1530/eje.0.1360196

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  8 in total

1.  Non-functioning adrenal incidentalomas caused by 21-hydroxylase deficiency or carrier status?

Authors:  Henrik Falhammar
Journal:  Endocrine       Date:  2014-01-23       Impact factor: 3.633

Review 2.  Clinical perspectives in congenital adrenal hyperplasia due to 11β-hydroxylase deficiency.

Authors:  Krupali Bulsari; Henrik Falhammar
Journal:  Endocrine       Date:  2016-12-07       Impact factor: 3.633

3.  Comparative analysis of plasma 17-hydroxyprogesterone and cortisol responses to ACTH in patients with various adrenal tumors before and after unilateral adrenalectomy.

Authors:  M Tóth; K Rácz; V Adleff; I Varga; L Fütö; C Jakab; K Karlinger; R Kiss; E Gláz
Journal:  J Endocrinol Invest       Date:  2000-05       Impact factor: 4.256

4.  Defining Nonfunctioning Adrenal Adenomas on the Basis of the Occurrence of Hypocortisolism after Adrenalectomy.

Authors:  Cristina Eller-Vainicher; Valentina Morelli; Carmen Aresta; Antonio Stefano Salcuni; Alberto Falchetti; Vincenzo Carnevale; Luca Persani; Alfredo Scillitani; Iacopo Chiodini
Journal:  J Endocr Soc       Date:  2020-06-19

Review 5.  The role of 21-hydroxylase in the pathogenesis of adrenal masses: review of the literature and focus on our own experience.

Authors:  L Barzon; P Maffei; N Sonino; C Pilon; L Baldazzi; A Balsamo; O Del Maschio; G Masi; M Trevisan; M Pacenti; F Fallo
Journal:  J Endocrinol Invest       Date:  2007 Jul-Aug       Impact factor: 4.256

6.  Metabolomic Biomarkers in Urine of Cushing's Syndrome Patients.

Authors:  Alicja Kotłowska; Tomasz Puzyn; Krzysztof Sworczak; Piotr Stepnowski; Piotr Szefer
Journal:  Int J Mol Sci       Date:  2017-01-29       Impact factor: 5.923

7.  Decreased steroidogenic enzyme activity in benign adrenocortical tumors is more pronounced in bilateral lesions as determined by steroid profiling in LC-MS/MS during ACTH stimulation test.

Authors:  Fidéline Bonnet-Serrano; Maxime Barat; Anna Vaczlavik; Anne Jouinot; Lucas Bouys; Christelle Laguillier-Morizot; Corinne Zientek; Catherine Simonneau; Etienne Larger; Laurence Guignat; Lionel Groussin; Guillaume Assié; Jean Guibourdenche; Ioannis Nicolis; Marie-Claude Menet; Jérôme Bertherat
Journal:  Endocr Connect       Date:  2022-07-19       Impact factor: 3.221

8.  Adrenal Tumor Mimicking Non-Classic Congenital Adrenal Hyperplasia.

Authors:  Wen-Hsuan Tsai; Chian-Huey Wong; Shuen-Han Dai; Chung-Hsin Tsai; Yi-Hong Zeng
Journal:  Front Endocrinol (Lausanne)       Date:  2020-09-29       Impact factor: 5.555

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.